[go: up one dir, main page]

DK143088D0 - Praeparat til behandling eller forhindring af virale infektioner - Google Patents

Praeparat til behandling eller forhindring af virale infektioner

Info

Publication number
DK143088D0
DK143088D0 DK143088A DK143088A DK143088D0 DK 143088 D0 DK143088 D0 DK 143088D0 DK 143088 A DK143088 A DK 143088A DK 143088 A DK143088 A DK 143088A DK 143088 D0 DK143088 D0 DK 143088D0
Authority
DK
Denmark
Prior art keywords
treating
preparation
viral infections
preventing viral
steroids
Prior art date
Application number
DK143088A
Other languages
English (en)
Other versions
DK143088A (da
Inventor
Anthony Atkinson
Graham Lloyd
Peter Morgan Sutton
Original Assignee
Health Lab Service Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Lab Service Board filed Critical Health Lab Service Board
Publication of DK143088D0 publication Critical patent/DK143088D0/da
Publication of DK143088A publication Critical patent/DK143088A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK143088A 1987-03-17 1988-03-16 Praeparat til behandling eller forhindring af virale infektioner DK143088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878706313A GB8706313D0 (en) 1987-03-17 1987-03-17 Treatment & prevention of viral infections

Publications (2)

Publication Number Publication Date
DK143088D0 true DK143088D0 (da) 1988-03-16
DK143088A DK143088A (da) 1988-09-18

Family

ID=10614085

Family Applications (1)

Application Number Title Priority Date Filing Date
DK143088A DK143088A (da) 1987-03-17 1988-03-16 Praeparat til behandling eller forhindring af virale infektioner

Country Status (10)

Country Link
US (1) US4957910A (da)
EP (1) EP0285285B1 (da)
JP (1) JPS63301823A (da)
AT (1) ATE106729T1 (da)
AU (1) AU619174B2 (da)
CA (1) CA1317224C (da)
DE (1) DE3889964T2 (da)
DK (1) DK143088A (da)
GB (1) GB8706313D0 (da)
ZA (1) ZA881856B (da)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO178843C (no) * 1988-07-11 1996-06-19 Sspl Sa Safe Sex Prod Licens Fremgangsmåte for fremstilling av et farmasöytisk preparat for å forhindre seksuelt overförbare sykdommer
EP0435926A1 (en) * 1988-09-20 1991-07-10 FISONS plc Bile acids for treatment of viral infections
DK603988D0 (da) * 1988-10-28 1988-10-28 Klaus Bendtzen Farmaceutisk praeparat
US5079240A (en) * 1990-03-15 1992-01-07 The Regents Of The University Of California Synthetic conjugated bile acid and method of use thereof
US5206008A (en) * 1991-04-15 1993-04-27 Virginia Commonwealth University Enhancement of immune response
IT1255450B (it) * 1992-06-30 1995-10-31 Montefarmaco Spa Uso di acidi biliari come agenti antivirali
US5639866A (en) * 1993-02-23 1997-06-17 Princeton University Single-step formation of multiple glycosidic linkages
JPH08511234A (ja) * 1993-02-23 1996-11-26 ザ トラスティーズ オブ プリンストン ユニヴァーシティー グリコシド結合の溶液及び固相形成
DE4316347C1 (de) * 1993-02-26 1994-08-18 Ina Dr Levi Verfahren zur Herstellung einer pharmazeutischen Zubereitung und Verwendung derselben zur Behandlung bestimmter Erkrankungen
EP0773029A4 (en) * 1993-07-19 1997-09-03 Tokyo Tanabe Co HEPATITIS C VIRUS PROLIFERATION INHIBITOR
CA2171281C (en) * 1993-09-09 1998-12-29 Romeo Rang Immunomodulating compositions from bile
US6551623B1 (en) 1993-09-09 2003-04-22 Lorus Therapeutics Inc. Immunomodulating compositions from bile
US5658560A (en) * 1994-01-18 1997-08-19 Serikov; Vladimir B. Method of treating endotoxemia by administering tyloxapol
US5646316A (en) * 1994-04-08 1997-07-08 Osteoarthritis Sciences, Inc. Bile acid inhibitors of metalloproteinase enzymes
EP0814821A1 (en) 1995-03-16 1998-01-07 Imutec Pharma Inc. Immunomodulating compositions from bile for the treatment of immune system disorders
IT1282943B1 (it) * 1995-12-27 1998-04-02 Sanofi Winthrop S P A Composizione farmaceutica iniettabile__a base di acido ursodesossicoli co o tauroursodesossicolico
DE19631122A1 (de) * 1996-08-01 1998-02-05 Falk Pharma Gmbh Verwendung von Ursodeoxycholsäure bei HIV-Infektion
US7169889B1 (en) * 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
EP1333847A1 (en) * 2000-11-08 2003-08-13 Lorus Therapeutics Inc. Combination preparation of a biological response modidier and an anticancer agent and uses thereof
WO2002051428A1 (fr) * 2000-12-25 2002-07-04 Shiseido Company, Ltd. Composition de parfum stimulant le systeme sympathique
US7060675B2 (en) 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6828305B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7713932B2 (en) 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
WO2002102363A1 (en) * 2001-06-20 2002-12-27 Lorus Therapeutics Inc. Biological response modifier composition and uses thereof
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en) * 2001-09-07 2004-08-03 Nobex Corporation Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US7030082B2 (en) * 2001-09-07 2006-04-18 Nobex Corporation Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
WO2003105768A2 (en) * 2002-06-13 2003-12-24 Nobex Corporation Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
CN101027318B (zh) 2004-07-19 2016-05-25 比奥孔有限公司 胰岛素-低聚物共轭物，制剂及其用途
CN101939023B (zh) 2007-10-16 2016-08-03 百康有限公司 可经口给药的固体药物组合物及其方法
CN103570790B (zh) * 2012-08-07 2016-06-01 中国科学院上海药物研究所 原人参二醇衍生物及其制备方法、包含该衍生物的组合物及其用途
WO2016145216A1 (en) * 2015-03-10 2016-09-15 Metselex, Inc. Fluorinated and alkylated bile acids
KR20220098682A (ko) 2019-05-14 2022-07-12 타임, 인크. 암을 치료하기 위한 조성물 및 방법
WO2021231931A1 (en) * 2020-05-14 2021-11-18 Tyme, Inc. Methods of treating sars-cov-2 infections
US10905698B1 (en) * 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE44263B1 (en) * 1975-12-03 1981-09-23 Leo Pharm Prod Ltd New fusidic acid derivatives
GB8417895D0 (en) * 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition

Also Published As

Publication number Publication date
EP0285285B1 (en) 1994-06-08
JPS63301823A (ja) 1988-12-08
AU619174B2 (en) 1992-01-23
CA1317224C (en) 1993-05-04
AU1321688A (en) 1988-09-15
DE3889964T2 (de) 1994-09-15
DK143088A (da) 1988-09-18
DE3889964D1 (de) 1994-07-14
ATE106729T1 (de) 1994-06-15
ZA881856B (en) 1989-04-26
US4957910A (en) 1990-09-18
GB8706313D0 (en) 1987-04-23
EP0285285A3 (en) 1990-12-05
EP0285285A2 (en) 1988-10-05

Similar Documents

Publication Publication Date Title
DK143088A (da) Praeparat til behandling eller forhindring af virale infektioner
ES2194902T3 (es) L-nucleosidos para el tratamiento del virus de la hepatitis b y el virus de epstein barr.
DK0428642T3 (da) Anvendelse af C-22 til C-26 alifatiske alkoholer til behandling af betændelses- og virussygdomme
EP0786458A3 (en) Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
ATE395922T1 (de) Lipid-analoge zur behandlung von viralen infektionen
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
NO883564L (no) Topisk aktive preparater av dobbeltraadet rna.
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
DE229016T1 (de) Interleukin-2-zusammensetzungen.
DK538888D0 (da) Anvendelse af castanosperminestere til fremstilling af et farmaceutisk praeparat
ATE82294T1 (de) Therapeutische nukleoside.
BG44537A3 (en) Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
UA13377A (uk) Спосіб одержаhhя противірусhого засобу
EE9400068A (et) Ravimsegud viirushepatiidi B (HBV) infektsiooni ja selle poolt p6hjustatud haiguste raviks ja nende valmistamise protsess
EP0234405A3 (en) Process for the preparation of an immunoglobulin-containing composition, and its use in the prophylaxis and therapy of aids
JPS51118820A (en) A process for preparing heat stable macroglobulin
ATE110278T1 (de) Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.
RU93048868A (ru) Способ безопасного введения жирных кислот, его применение для лечения рака, инфекционных вирусных заболеваний и других нарушений
ATE88752T1 (de) Inaktivierung von human immunodeficiency virus (hiv) in proteinhaltigen loesungen durch phenole.
SE7904840L (sv) Antiviralt verksamma t-rna-preparat
ATE335494T1 (de) Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen
DE59002790D1 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO).
SE8008456L (sv) Komposition och framstellning derav

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment